JP2008519841A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008519841A5 JP2008519841A5 JP2007541306A JP2007541306A JP2008519841A5 JP 2008519841 A5 JP2008519841 A5 JP 2008519841A5 JP 2007541306 A JP2007541306 A JP 2007541306A JP 2007541306 A JP2007541306 A JP 2007541306A JP 2008519841 A5 JP2008519841 A5 JP 2008519841A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- ovr110
- pta
- cancer
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62681704P | 2004-11-10 | 2004-11-10 | |
| US60/626,817 | 2004-11-10 | ||
| PCT/US2005/040707 WO2006053110A2 (en) | 2004-11-10 | 2005-11-10 | Ovr110 antibody compositions and methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008519841A JP2008519841A (ja) | 2008-06-12 |
| JP2008519841A5 true JP2008519841A5 (https=) | 2009-10-01 |
| JP5173428B2 JP5173428B2 (ja) | 2013-04-03 |
Family
ID=36337204
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007541306A Expired - Fee Related JP5173428B2 (ja) | 2004-11-10 | 2005-11-10 | Ｏｖｒ１１０抗体組成物および使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20090136490A1 (https=) |
| EP (1) | EP1817055B1 (https=) |
| JP (1) | JP5173428B2 (https=) |
| AU (1) | AU2005304462B2 (https=) |
| CA (1) | CA2586313C (https=) |
| DK (1) | DK1817055T3 (https=) |
| ES (1) | ES2402277T3 (https=) |
| IL (1) | IL182943A0 (https=) |
| WO (1) | WO2006053110A2 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2230517A1 (en) * | 2005-01-07 | 2010-09-22 | Diadexus, Inc. | OVR110 antibody compositions and methods of use |
| US8759490B2 (en) | 2005-03-24 | 2014-06-24 | Millennium Pharamaceuticals, Inc. | Antibodies that bind OV064 and methods of use therefor |
| US8323645B2 (en) | 2005-03-24 | 2012-12-04 | Millennium Pharmaceuticals, Inc. | Antibodies that bind OV064 and methods of use therefor |
| WO2007067991A2 (en) | 2005-12-08 | 2007-06-14 | Medarex, Inc. | Human monoclonal antibodies to o8e |
| JP5391073B2 (ja) * | 2006-11-27 | 2014-01-15 | ディアデクサス インコーポレーテッド | Ｏｖｒ１１０抗体組成物および使用方法 |
| EP2409712A1 (en) * | 2010-07-19 | 2012-01-25 | International-Drug-Development-Biotech | Anti-CD19 antibody having ADCC and CDC functions and improved glycosylation profile |
| EP2409993A1 (en) * | 2010-07-19 | 2012-01-25 | International-Drug-Development-Biotech | Anti-CD19 antibody having ADCC function with improved glycosylation profile |
| WO2012145568A1 (en) | 2011-04-21 | 2012-10-26 | Albert Einstein College Of Medicine Of Yeshiva University | Antibodies to human b7x for treatment of metastatic cancer |
| US9676854B2 (en) * | 2011-08-15 | 2017-06-13 | Medimmune, Llc | Anti-B7-H4 antibodies and their uses |
| US9562099B2 (en) * | 2013-03-14 | 2017-02-07 | Genentech, Inc. | Anti-B7-H4 antibodies and immunoconjugates |
| JP6436965B2 (ja) * | 2013-03-14 | 2018-12-12 | ジェネンテック， インコーポレイテッド | 抗ｂ７−ｈ４抗体及びイムノコンジュゲート |
| WO2016040724A1 (en) * | 2014-09-12 | 2016-03-17 | Genentech, Inc. | Anti-b7-h4 antibodies and immunoconjugates |
| PE20181326A1 (es) | 2015-11-03 | 2018-08-20 | Janssen Biotech Inc | Anticuerpos que se unen especificamente a pd-1 y sus usos |
| EP4649966A3 (en) | 2016-12-01 | 2026-02-18 | Regeneron Pharmaceuticals, Inc. | Radiolabeled anti-pd-l1 antibodies for immuno-pet imaging |
| US11306144B2 (en) | 2017-08-25 | 2022-04-19 | Five Prime Therapeutics, Inc. | B7-H4 antibodies and methods of use thereof |
| US12398209B2 (en) | 2018-01-22 | 2025-08-26 | Janssen Biotech, Inc. | Methods of treating cancers with antagonistic anti-PD-1 antibodies |
| BR112020016986A2 (pt) | 2018-02-21 | 2021-03-02 | Five Prime Therapeutics, Inc. | formulações de anticorpo contra b7-h4 |
| KR20200144094A (ko) | 2018-03-02 | 2020-12-28 | 파이브 프라임 테라퓨틱스, 인크. | B7-h4 항체 및 이의 사용 방법 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| DD266710A3 (de) | 1983-06-06 | 1989-04-12 | Ve Forschungszentrum Biotechnologie | Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase |
| US4879231A (en) | 1984-10-30 | 1989-11-07 | Phillips Petroleum Company | Transformation of yeasts of the genus pichia |
| GB8610600D0 (en) | 1986-04-30 | 1986-06-04 | Novo Industri As | Transformation of trichoderma |
| EP0402226A1 (en) | 1989-06-06 | 1990-12-12 | Institut National De La Recherche Agronomique | Transformation vectors for yeast yarrowia |
| PT616812E (pt) | 1993-03-24 | 2000-04-28 | Berlex Biosciences | Combinacao de compostos anti-hormonais e moleculas de ligacao no tratamento do cancro |
| WO2000012758A1 (en) * | 1998-09-02 | 2000-03-09 | Diadexus Llc | A novel method of diagnosing, monitoring, staging, imaging and treating various cancers |
| US20020119158A1 (en) | 1998-12-17 | 2002-08-29 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of ovarian cancer |
| WO2002002624A2 (en) * | 2000-06-30 | 2002-01-10 | Amgen, Inc. | B7-like molecules and uses thereof |
| AU2002258518A1 (en) * | 2001-03-14 | 2002-09-24 | Millennium Pharmaceuticals, Inc. | Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
| EP1539218A4 (en) * | 2002-06-20 | 2007-08-22 | Univ California | COMPOSITIONS AND METHODS FOR MODULATING LYMPHOCYTE ACTIVITY |
| WO2004101756A2 (en) | 2003-05-09 | 2004-11-25 | Diadexus, Inc. | Ovr110 antibody compositions and methods of use |
-
2005
- 2005-11-10 JP JP2007541306A patent/JP5173428B2/ja not_active Expired - Fee Related
- 2005-11-10 EP EP05848912A patent/EP1817055B1/en not_active Expired - Lifetime
- 2005-11-10 WO PCT/US2005/040707 patent/WO2006053110A2/en not_active Ceased
- 2005-11-10 AU AU2005304462A patent/AU2005304462B2/en not_active Ceased
- 2005-11-10 ES ES05848912T patent/ES2402277T3/es not_active Expired - Lifetime
- 2005-11-10 CA CA2586313A patent/CA2586313C/en not_active Expired - Lifetime
- 2005-11-10 DK DK05848912.1T patent/DK1817055T3/da active
- 2005-11-10 US US11/719,003 patent/US20090136490A1/en not_active Abandoned
-
2007
- 2007-05-02 IL IL182943A patent/IL182943A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5570218B2 (ja) | Ｆｇｆｒ４抗体 | |
| US9409994B2 (en) | High-affinity monoclonal antibodies to glypican-3 and use thereof | |
| EP3252076B1 (en) | Diagnostic use of antibodies against ror-1 protein | |
| JP5631733B2 (ja) | 抗ＥｐＣＡＭ抗体およびその使用 | |
| JP2008519841A5 (https=) | ||
| US12364770B2 (en) | Antibodies specific to MUC18 | |
| CN115368458A (zh) | 抗cd73抗体及其应用 | |
| AU2021217624A1 (en) | Anti-MEFLIN antibody for use in treatment of cancer in subject having cancer, and pharmaceutical composition comprising the antibody | |
| US12173081B2 (en) | CD19/CD38 multispecific antibodies | |
| US20230085269A1 (en) | Anti- muc1-sea antibodies | |
| WO2022228183A1 (zh) | 抗siglec15抗体及其制备方法和用途 | |
| KR20240057529A (ko) | 신규 항-cdcp1 항체 및 이의 용도 | |
| CN115594762A (zh) | 一种铁蛋白重链抗体及其用途 | |
| IL317725A (en) | An antibody targeting ITGA2 and a drug conjugate antibody containing it | |
| CN117624352A (zh) | 抗Tmem176b抗体、药物组合物及用途 | |
| CN120383678A (zh) | 识别磷脂酰肌醇蛋白聚糖3多个不同表位的抗体及其应用 | |
| WO2023190465A1 (ja) | 抗ヒトｓｅｍａ７ａ抗体 | |
| AU2023451019A1 (en) | Antibody targeting itga2, antibody drug conjugate thereof, and use | |
| JP7017581B2 (ja) | Ｐａｕｆタンパク質に特異的に結合する抗体及びその用途 | |
| KR20240099470A (ko) | 항-cldn18.2 단일클론 항체 및 이의 응용 | |
| CN121824756A (zh) | 一种cldn3单克隆抗体及其应用 | |
| CN121627886A (zh) | 一种特异性结合催乳素受体prlr的小鼠单克隆抗体及其应用 | |
| CN121824757A (zh) | 一种能够结合催乳素受体prlr的抗体及其用途 | |
| CN121673408A (zh) | 一种特异性结合prlr的小鼠单克隆抗体及其应用 | |
| CN119101159A (zh) | 抗tim-3单克隆抗体及其制备方法和应用 |